Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-25FDA Approved: CLOZAPINE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for clozapine, granting approval for a generic clozapine product.
-
FDA approval · 2015-11-19FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for ziprasidone from Dr. Reddy's Laboratories Limited, approving a generic version under the AND…
-
FDA approval · 2015-11-10FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc. The action indicates an appro…
-
FDA approval · 2015-11-05FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the generic olanzapine product manufactured by Macleods Pharmaceuticals Limited under ANDA 20286…
-
FDA approval · 2015-11-03FDA Approved: CHLORPROMAZINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.,)
FDA approved a supplemental application for chlorpromazine HCl from Dr. Reddy's Laboratories, authorizing the generic version to be marketed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-10-22FDA Approved: RISPERIDONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for Risperidone from Jubilant Cadista Pharmaceuticals Inc., signifying an approval related to this g…
-
FDA approval · 2015-10-20FDA Approved: OLANZAPINE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's original application to manufacture and market a generic olanzapine product.
-
FDA approval · 2015-10-08FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA has approved a supplemental application for Clozaril (clozapine) filed by HLS Therapeutics (USA), Inc.
-
FDA approval · 2015-10-05FDA Approved: ARISTADA — Original Application (Alkermes, Inc.)
FDA approved Aristada (aripiprazole lauroxil) through Alkermes' Original Application, introducing a long-acting injectable antipsychotic. It…
-
FDA approval · 2015-09-30FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
FDA approved a supplemental application for VERSACLOZ (clozapine) submitted by TruPharma LLC.
-
FDA approval · 2015-09-30FDA Approved: ARIPIPRAZOLE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s Original Application for aripiprazole, granting approval of a generic version of the antipsychotic.
-
FDA approval · 2015-09-24FDA Approved: PALIPERIDONE — Original Application (Archis Pharma LLC)
FDA approved Archis Pharma LLC's paliperidone original application, authorizing a generic paliperidone product. Paliperidone is used to trea…
-
FDA approval · 2015-09-18FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for CLOZARIL (clozapine) submitted by HLS Therapeutics (USA), Inc., signaling an update to the produ…
-
FDA approval · 2015-09-17FDA Approved: VRAYLAR — Original Application (Allergan, Inc.)
The FDA approved VRAYLAR (cariprazine) under the original application NDA204370 for the treatment of schizophrenia and manic or mixed episod…
-
FDA approval · 2015-09-17FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2015-09-15FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc.
-
FDA approval · 2015-09-15FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc., updating/expanding the produ…
-
FDA approval · 2015-09-15FDA Tentative Approval: CLOZAPINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA issued tentative approval for a generic Clozapine from Mylan Pharmaceuticals Inc. under ANDA201824, allowing U.S. marketing for approved…
-
FDA approval · 2015-09-04FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for quetiapine fumarate from Hikma Pharmaceuticals USA, indicating approval of changes to the pr…
-
FDA approval · 2015-08-27FDA Approved: RISPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for risperidone from Ajanta Pharma USA Inc., indicating an approved regulatory action for this p…
-
FDA approval · 2015-08-21FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited, providing a generic version of the antips…
-
FDA approval · 2015-08-20FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone mesylate) submitted by Viatris Specialty LLC to update the approved product.
-
FDA approval · 2015-08-20FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) from Viatris Specialty LLC.
-
FDA approval · 2015-08-14FDA Approved: ARIPIPRAZOLE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's original ANDA for aripiprazole (ARIPIPRAZOLE), enabling the marketing of a generic version of this antipsychotic.
-
FDA approval · 2015-08-12FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
FDA approved a supplemental application for chlorpromazine hydrochloride from Saptalis Pharmaceuticals, LLC.